US3340276A
(en)
|
1964-04-01 |
1967-09-05 |
Ciba Geigy Corp |
3, 4-diphenyl-chromans
|
DE1518002C3
(de)
|
1965-01-02 |
1975-01-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
|
DE1543749A1
(de)
|
1966-02-16 |
1969-12-11 |
Merck Ag E |
Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
|
GB1433013A
(pl)
|
1973-06-08 |
1976-04-22 |
|
|
US4157984A
(en)
|
1977-06-08 |
1979-06-12 |
Z-L Limited |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
US4218489A
(en)
|
1977-06-08 |
1980-08-19 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
US4264509A
(en)
|
1977-06-08 |
1981-04-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
US4232122A
(en)
|
1979-01-17 |
1980-11-04 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
US4234577A
(en)
|
1979-03-19 |
1980-11-18 |
Z-L Limited Partnership |
Ergostadientriols, compositions containing same, and methods of preparing and using same
|
US4368264A
(en)
|
1979-03-19 |
1983-01-11 |
Z-L Limited Partnership |
Fermentation methods of preparing ergostadientriols
|
US4390559A
(en)
|
1979-04-11 |
1983-06-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
US4366248A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Fermentation method of preparing antioxidants
|
US4366082A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
US4447622A
(en)
|
1981-09-22 |
1984-05-08 |
Council Of Scientific And Industrial Research Rafi Marg |
Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
|
US4644012A
(en)
|
1983-12-21 |
1987-02-17 |
Takeda Chemical Industries, Ltd. |
Treatment for osteoporosis
|
GB8626344D0
(en)
|
1986-11-04 |
1986-12-03 |
Zyma Sa |
Bicyclic compounds
|
MX13485A
(es)
|
1987-10-19 |
1993-05-01 |
Pfizer |
Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
|
US5059609A
(en)
|
1987-10-19 |
1991-10-22 |
Pfizer Inc. |
Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
EP0470310B1
(en)
|
1990-08-09 |
1995-11-29 |
Council of Scientific and Industrial Research |
Novel benzopyrans and process for their production
|
JPH07507811A
(ja)
|
1992-10-21 |
1995-08-31 |
ファイザー・インク. |
鏡像異性のシス−3−(4,6−ジヒドロキシクロマン−3−イル−メチル)安息香酸
|
US5280040A
(en)
|
1993-03-11 |
1994-01-18 |
Zymogenetics, Inc. |
Methods for reducing bone loss using centchroman derivatives
|
US5451603A
(en)
|
1993-03-11 |
1995-09-19 |
Zymogenetics, Inc. |
3,4-diarylchromans for treatment of dermatitis
|
US5389646A
(en)
|
1993-12-30 |
1995-02-14 |
Zymogenetics, Inc. |
Methods for treatment and prevention of bone loss using 2,3-benzopyrans
|
US5792776A
(en)
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
CN1168098A
(zh)
|
1995-01-13 |
1997-12-17 |
诺沃挪第克公司 |
3,4-二苯基苯并二氢吡喃在生产用于治疗或预防高脂蛋白血症、高甘油三酯血症、高脂血症或高胆固醇血症或动脉硬化或用于抗凝治疗的药物组合物中的用途
|
HUP9702244A3
(en)
|
1995-01-13 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
|
BR9606754A
(pt)
|
1995-01-13 |
1998-01-06 |
Novo Nordisk As |
Uso de compostos processo para tratamento e profilaxia de ginecomastia idiopática ou fisiológia e novo detalhe característico ou combinação de detalhes
|
HUP9702246A3
(en)
|
1995-01-20 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of degenerative cerebral disorders
|
TW448046B
(en)
|
1995-01-20 |
2001-08-01 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
|
WO1996022093A1
(en)
|
1995-01-20 |
1996-07-25 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
|
US5849461A
(en)
|
1995-08-01 |
1998-12-15 |
Shin-Etsu Chemical Co., Ltd. |
Chemically amplified positive resist composition
|
KR19990077156A
(ko)
|
1996-01-11 |
1999-10-25 |
한센 핀 베네드, 안네 제헤르 |
폐경기 증상의 치료 또는 예방을 위한 약학적 조성물의제조를 위한 3,4-디페닐크로만의 사용
|
US5726202A
(en)
|
1996-01-11 |
1998-03-10 |
Novo Nordisk A/S |
Benign prostatic hypertrophy
|
US5883118A
(en)
|
1996-01-11 |
1999-03-16 |
Nova Nordisk A/S |
Prostatic carcinoma
|
US5747059A
(en)
|
1996-01-11 |
1998-05-05 |
Novo Nordisk A/S |
Atrophy of skin/mucous membrane
|
US5756539A
(en)
|
1996-07-11 |
1998-05-26 |
Novo Nordis A/S |
3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
|
JP2000514443A
(ja)
|
1996-07-12 |
2000-10-31 |
ノボ ノルディスク アクティーゼルスカブ |
眼内圧を下げるための医薬組成物の製造のための3,4―ジフェニルクロマンの使用
|
WO1998002154A1
(en)
|
1996-07-12 |
1998-01-22 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
|
AUPO203996A0
(en)
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
GB9621757D0
(en)
|
1996-10-18 |
1996-12-11 |
Ciba Geigy Ag |
Phenyl-substituted bicyclic heterocyclyl derivatives and their use
|
ZA979643B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
ZA979646B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
US5919817A
(en)
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
AU4700097A
(en)
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6043269A
(en)
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5985306A
(en)
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
US5958967A
(en)
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
DK0937062T3
(da)
|
1996-10-28 |
2003-04-07 |
Novo Nordisk As |
Nye cis-3,4-chroman-derivater, der er nyttige i forebyggelsen eller behandlingen af østrogen-relaterede sygdomme eller syndromer
|
WO1998018776A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
IL129625A0
(en)
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
ZA979644B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
WO1998018770A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
A process for the preparation of (-)-3,4-trans-diarylchromans
|
WO1998018778A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5994390A
(en)
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
CN1120162C
(zh)
|
1996-12-13 |
2003-09-03 |
中外制药株式会社 |
新的苯并吡喃衍生物
|
AU5550398A
(en)
|
1997-01-29 |
1998-08-25 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting senescence-associated motor impairment
|
WO1998032437A1
(en)
|
1997-01-29 |
1998-07-30 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
|
WO1998033499A1
(en)
|
1997-01-29 |
1998-08-06 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for increasing libido in post-menopausal women
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
AUPP112497A0
(en)
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
WO1999049862A1
(en)
|
1998-03-30 |
1999-10-07 |
The University Of Mississippi |
Isoflavones for treating giardiasis and malaria
|
JP2002512807A
(ja)
|
1998-04-28 |
2002-05-08 |
ノボ ノルディスク アクティーゼルスカブ |
(−)−3.4−トランス−ジアリールクロマンを得るための酵素的分割
|
FR2778404B1
(fr)
|
1998-05-06 |
2000-06-30 |
Hoechst Marion Roussel Inc |
Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
KR20000001793A
(ko)
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
FR2789685B1
(fr)
|
1999-02-15 |
2001-05-04 |
Univ Lille Sciences Tech |
Procede de fabrication de polymeres solubles et insolubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s) et polymeres solubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s)
|
AUPP868599A0
(en)
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
AUPQ008299A0
(en)
|
1999-04-30 |
1999-05-27 |
G.J. Consultants Pty Ltd |
Isoflavone metabolites
|
AU6315300A
(en)
|
1999-07-26 |
2001-02-13 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
AUPQ266199A0
(en)
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
WO2001026651A2
(en)
|
1999-10-14 |
2001-04-19 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
|
EP1241165A4
(en)
|
1999-12-13 |
2003-03-19 |
Chugai Pharmaceutical Co Ltd |
OPTICALLY ACTIVE CHROMANE AND THIOCHROMANE DERIVATIVES
|
US6479467B1
(en)
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
CA2395730A1
(en)
|
2000-01-28 |
2001-08-02 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in combination with estrogens
|
DE60117777T2
(de)
|
2000-05-11 |
2006-08-17 |
Eastman Chemical Co., Kingsport |
Acylierte zyclodextrin guest-inklusion komplexe
|
FI20001593A
(fi)
|
2000-07-03 |
2002-01-04 |
Orion Yhtymo Oyj |
Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
|
CN1250505C
(zh)
|
2000-08-31 |
2006-04-12 |
科学工业研究院 |
制备1-丙基-2,4,5-三甲氧基苯的改进方法
|
JP2005503446A
(ja)
|
2001-01-11 |
2005-02-03 |
イーストマン ケミカル カンパニー |
シクロデキストリンスルホネート、ゲスト包接錯体、その製造方法及び関連物質
|
ATE286894T1
(de)
|
2001-01-24 |
2005-01-15 |
Chiesi Farma Spa |
2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
|
DE60211132T2
(de)
|
2001-02-14 |
2006-09-28 |
Akzo Nobel N.V. |
2-alkylierte cyclodextrin-derivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung
|
WO2003016270A2
(en)
|
2001-08-11 |
2003-02-27 |
Bristol-Myers Squibb Pharma Company |
Selective estrogen receptor modulators
|
WO2003022994A2
(en)
|
2001-09-06 |
2003-03-20 |
Synorx, Inc. |
Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
JP2005524630A
(ja)
|
2002-01-14 |
2005-08-18 |
ノルディック・ビオサイエンス・エー/エス |
エストロゲン受容体を介する軟骨破壊の抑制
|
WO2003086386A1
(en)
|
2002-04-09 |
2003-10-23 |
Novogen Research Pty Ltd |
Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
|
AU2002951833A0
(en)
|
2002-10-02 |
2002-10-24 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods invloving platinum complexes
|
EP1549269A4
(en)
|
2002-10-09 |
2010-10-06 |
Cerulean Pharma Inc |
CYCLODEXTRIN BASED MATERIALS, COMPOSITIONS AND ITS USE
|
EP1685140A4
(en)
|
2003-11-18 |
2009-02-25 |
Novogen Res Pty Ltd |
PRODRUGS BASED ON ISOFLAVONOIDS, COMPOSITIONS THEREOF AND THERAPEUTIC PROCESSES INVOLVING THEM
|
WO2005049008A1
(en)
|
2003-11-19 |
2005-06-02 |
Novogen Research Pty Ltd |
Combinational radiotherapy and chemotherapy compositions and methods
|
DE102004002787A1
(de)
|
2004-01-19 |
2005-08-11 |
Merck Patent Gmbh |
Flavonoid-Komplexe
|
AU2005287865B2
(en)
|
2004-09-21 |
2012-02-16 |
Marshall Edwards, Inc. |
Substituted chroman derivatives, medicaments and use in therapy
|
ES2516067T3
(es)
|
2004-09-21 |
2014-10-30 |
Mei Pharma, Inc. |
Derivados de cromano sustituidos, medicamentos y utilización en terapia
|
EP1809618B1
(en)
|
2004-09-21 |
2013-07-17 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
JP4976649B2
(ja)
|
2004-09-21 |
2012-07-18 |
マーシャル エドワーズ,インク. |
化合物
|
CA2668008A1
(en)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention and reversal of chemotherapy-induced peripheral neuropathy
|
AU2008229617A1
(en)
|
2007-03-16 |
2008-09-25 |
Novogen Research Pty Ltd |
Method for inducing autophagy
|
US20120039917A1
(en)
|
2008-08-29 |
2012-02-16 |
Alan James Husband |
Immunomodulating activities
|
CA2641541A1
(en)
*
|
2008-10-22 |
2010-04-22 |
Novogen Research Pty Ltd. |
Methods for inducing programmed cell death
|
US20100130598A1
(en)
|
2008-10-22 |
2010-05-27 |
Novogen Research Pty Ltd. |
Methods for inducing programmed cell death
|
EP2635121B1
(en)
*
|
2010-11-01 |
2020-01-08 |
MEI Pharma, Inc. |
Isoflavonoid compounds and methods for the treatment of cancer
|
US20120251630A1
(en)
*
|
2011-03-29 |
2012-10-04 |
Marshall Edwards, Inc. |
Remission therapy of cancer with isoflavonoids
|
JP2015532272A
(ja)
*
|
2012-09-28 |
2015-11-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
二重アンジオポエチン−2/Dll4結合剤および抗VEGF−R剤を含む薬学的組み合わせ
|
PT2953938T
(pt)
|
2014-02-07 |
2017-10-09 |
Novogen ltd |
Compostos de benzopirano funcionais e sua utilização
|
PL3253208T3
(pl)
|
2015-02-02 |
2021-11-08 |
Mei Pharma, Inc. |
Terapie kombinowane do zastosowania w leczeniu nowotworu piersi
|